Comparison of Articaine and Prilocaine for Extraction of Maxillary Teeth
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04236115 |
Recruitment Status :
Completed
First Posted : January 22, 2020
Last Update Posted : January 22, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Overcoming the Failure of Anaesthesia Maxillary Teeth Dental Extraction | Drug: Articaine 4% Drug: Prilocain 3% Drug: Adrenalin Drug: Felypressin | Phase 4 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 95 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | double blinded randomised trial |
Masking: | Single (Participant) |
Primary Purpose: | Treatment |
Official Title: | Does Articaine, Rather Than Prilocaine, Increase the Success Rate of Anaesthesia for Extraction of Maxillary Teeth |
Actual Study Start Date : | September 20, 2017 |
Actual Primary Completion Date : | April 20, 2018 |
Actual Study Completion Date : | June 20, 2018 |

Arm | Intervention/treatment |
---|---|
Active Comparator: Articaine 4% with 1:00.000 Adrenaline
if the patient was in articaine group, buccal infiltration technique was applied by inserting a short needle at the height of buccal sulcus along the long axis of the subject tooth for extraction.
|
Drug: Articaine 4%
Articaine 4% is dental local anaesthetic agent Drug: Adrenalin adrenaline is a vasoconstrictor |
Active Comparator: Prilocaine with 3% Felypressin (0.03 I.U. per ml)
if the patient was in prelocaine group, buccal infiltration technique was applied by inserting a short needle at the height of buccal sulcus along the long axis of the subject tooth for extraction.
|
Drug: Prilocain 3%
prilocaine is dental local anaesthetic agent Drug: Felypressin Felypressin is a vasoconstrictor |
- Does articaine, rather than prilocaine, increase the success rate of anaesthesia for extraction of maxillary teeth [ Time Frame: 6 months ]to compare the anaesthetic performances of 3% prilocaine (the safest local anaesthetic) with 4 % articaine (the local anaesthetic with fastest onset time of action) when used for maxillary teeth extraction

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 16 Years to 70 Years (Child, Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients have one or two upper teeth for extraction, subject tooth or its adjacent must be vital, healthy patient or patient with mild systemic diseases (class I or II according to American Society of Anesthesiology).
Exclusion Criteria:
- Patients excluded from this study if they have allergy to local anaesthetic agents or need surgical, or multiple teeth extraction.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04236115
Saudi Arabia | |
Taibah University | |
Medina, Saudi Arabia, 41311 |
Responsible Party: | Giath Gazal, Associate Professor, Taibah University |
ClinicalTrials.gov Identifier: | NCT04236115 |
Other Study ID Numbers: |
Taibah dental College |
First Posted: | January 22, 2020 Key Record Dates |
Last Update Posted: | January 22, 2020 |
Last Verified: | January 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Yes |
Plan Description: | it will be provided on demand |
Supporting Materials: |
Study Protocol Statistical Analysis Plan (SAP) Clinical Study Report (CSR) |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Product Manufactured in and Exported from the U.S.: | No |
Carticaine dental extraction injections prilocaine |
Felypressin Carticaine Anesthetics, Local Anesthetics Central Nervous System Depressants |
Physiological Effects of Drugs Sensory System Agents Peripheral Nervous System Agents Vasoconstrictor Agents |